A model for identifying HERG K+ channel blockers

被引:109
作者
Aronov, AM [1 ]
Goldman, BB [1 ]
机构
[1] Vertex Pharmaceut Inc, Cambridge, MA 02139 USA
关键词
HERG; QT prolongation; binary classification; pharmacophore; ensembles;
D O I
10.1016/j.bmc.2004.02.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acquired long QT syndrome (LQTS) occurs frequently as a side effect of blockade of cardiac HERG K+ channels by commonly used medications. A large number of structurally diverse compounds have been shown to inhibit K+ current through HERG. There is considerable interest in developing in silico tools to filter out potential HERG blockers early in the drug discovery process. We describe a binary classification model that combines a 21) topological similarity filter with a 3D pharmacophore ensemble procedure to discriminate between HERG actives and inactives with an overall accuracy of 82%, with false negative and false positive rates of 29% and 15%, respectively. This model should be generally applicable in virtual library counterscreening against HERG. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2307 / 2315
页数:9
相关论文
共 54 条
  • [11] De Ponti F, 2002, DRUG SAFETY, V25, P263
  • [12] The structure of the potassium channel:: Molecular basis of K+ conduction and selectivity
    Doyle, DA
    Cabral, JM
    Pfuetzner, RA
    Kuo, AL
    Gulbis, JM
    Cohen, SL
    Chait, BT
    MacKinnon, R
    [J]. SCIENCE, 1998, 280 (5360) : 69 - 77
  • [13] Egan WJ, 2002, CURR OPIN DRUG DISC, V5, P540
  • [14] Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel
    Ekins, S
    Crumb, WJ
    Sarazan, RD
    Wikel, JH
    Wrighton, SA
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (02) : 427 - 434
  • [15] Optimization of a tertiary alcohol series of phosphodiesterase-4 (PDE4) inhibitors:: Structure-activity relationship related to PDE4 inhibition and human ether-a-go-go related gene potassium channel binding affinity
    Friesen, RW
    Ducharme, Y
    Ball, RG
    Blouin, M
    Boulet, L
    Côté, B
    Frenette, R
    Girard, M
    Guay, D
    Huang, Z
    Jones, TR
    Laliberté, F
    Lynch, JJ
    Mancini, J
    Martins, E
    Masson, P
    Muise, E
    Pon, DJ
    Siegl, PKS
    Styhler, A
    Tsou, NN
    Turner, MJ
    Young, RN
    Girard, Y
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (12) : 2413 - 2426
  • [16] González T, 2001, J PHARMACOL EXP THER, V296, P573
  • [17] Open channel block of HERG K+ channels by vesnarinone
    Kamiya, K
    Mitcheson, JS
    Yasui, K
    Kodama, I
    Sanguinetti, MC
    [J]. MOLECULAR PHARMACOLOGY, 2001, 60 (02) : 244 - 253
  • [18] Antiarrhythmic drug carvedilol inhibits HERG potassium channels
    Karle, CA
    Kreye, VAW
    Thomas, D
    Röckl, K
    Kathöfer, S
    Zhang, W
    Kiehn, J
    [J]. CARDIOVASCULAR RESEARCH, 2001, 49 (02) : 361 - 370
  • [19] Chemical similarity using physiochemical property descriptors
    Kearsley, SK
    Sallamack, S
    Fluder, EM
    Andose, JD
    Mosley, RT
    Sheridan, RP
    [J]. JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1996, 36 (01): : 118 - 127
  • [20] Molecular genetic insights into cardiovascular disease
    Keating, MT
    Sanguinetti, MC
    [J]. SCIENCE, 1996, 272 (5262) : 681 - 685